AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
InspireMD welcomes the publication of CREST-2 data in the New England Journal of Medicine, which shows positive clinical outcomes for carotid artery stenting in patients with asymptomatic carotid stenosis. The study demonstrated that stenting led to better outcomes than intensive medical management alone, with a decreased risk of stroke or death. InspireMD's CGuard Prime stent system is designed for the prevention of stroke, and the company believes that CREST-2 data validates its innovative mesh-protected platform.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet